Register      Login

Editorial Board

1.
Biomarkers in Congestive Heart Failure: Clinical Importance

  • Amal K Banerjee dramalcsi09@gmail.com
    • 2.
    Clinical and Laboratory Assessment of Patients with Suspected Primary Aldosteronism

  • Richard J Auchus rauchus@med.umich.edu
    • 3.
    Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Ready to Target Atherosclerotic Cardiovascular Disease beyond Statins

  • Nidhi Mishra

  • Prabhash C Manoria pmanoria@rediffmail.com
    • 4.
    Renal Effects of Sodium-glucose-linked Transporter 2 Inhibitors

  • M Rajasekara Chakravarthi rajasekarac@gmail.com

  • Hari K Marri
    • 5.
    Treatment-Resistant Hypertension: A Pragmatic Management Approach

  • Brent M Egan began@ccihealth.org
    • 6.
    Assessment of End Organ Damage in Hypertension—Left Ventricular Hypertrophy

  • Mohan V Deshpande

  • Niteen V Deshpande nvdesh@hotmail.com
    • 7.
    Cardiovascular Protective Actions of Sodium Glucose Cotransporter 2 Inhibitors

  • Shamanna S Iyengar ssiyengar1945@gmail.com
    • 8.
    Hypertension in Pregnancy: Do We need a New Algorithm?

  • Tiny Nair tinynair@gmail.com

  • Akash Nair
    • 9.
    Increased Sympathetic Drive, Elevated Heart Rate, and the Cardiovascular Continuum

  • Brent M Egan began@ccihealth.org

    • © Jaypee Brothers Medical Publishers (P) LTD.